
Sensus Healthcare Launches Collaboration with BirchBioMed sensushealthcare.com/press-release/…
English
BirchBioMed
11 posts

@BirchBioMed
BirchBioMed Inc. is exclusively licenced by the University of British Columbia to develop anti-scarring drugs and autoimmune therapies based on FS2














BirchBioMed announces completion of clinical trial for ground-breaking anti-scarring drug bit.ly/2boNZmu
